Lipocine (LPCN) FCF Margin Growth (1y) (2024 - 2025)

Lipocine (LPCN) FCF Margin Growth (1y) (2024 - 2025) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Margin Growth (1y) (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-89.00
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-1,183.00
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	26,102.00
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	869.00
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	769.00
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	4,109.00
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	19,111.00
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	811.00
10	Lipocine	11.15 Mn	-12.76 Mn	-	-

Download Data